PHAR Latest Headlines

Oppenheimer Remains a Buy on Pharming Group (PHAR)

at www.tipranks.com (Wed, 28-Oct 8:36 AM)

Pantginis Maintains Buy on Strong Ruconest and Joenja Momentum; $37 Price Target Reaffirmed

at www.tipranks.com (Tue, 27-Oct 12:35 PM)

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Pharming Group (PHAR) and BioNTech SE (BNTX)

at www.tipranks.com (Fri, 23-Oct 8:10 AM)